Patients Medical Professionals Careers Investors Therapy Sites Global Sites About Us Research & Pipeline Therapies Responsibility Newsroom A TRANSFORMATIVE AGE OF NEUROLOGY As a leading company in the fight against multiple sclerosis, Biogen is applying its expertise to help address some of the most challenging and complex diseases of the brain. Learn More Innovative therapies We develop medicines for debilitating medical conditions with the goal of making a meaningful difference in patients’ lives. More about our therapies FILTER BY All approved therapies Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Spinal Muscular Atrophy Biosimilars Biosimilars Partnered Partnered Dedicated to new discoveries Our pipeline is more than a list of medicines in development. It reflects the work we do here every day to break new ground with science that makes a difference in the lives of patients. Filter by: All disease areas All phases Phase 1 2 3 Filed Aducanumab (Aβ mAb) Alzheimer’s disease E2609 (BACE1 inhibitor) Alzheimer's disease Obinutuzumab Front-line Indolent non-Hodgkin’s lymphoma BAN2401 (Aβ mAb) Alzheimer’s disease See full pipeline Caring deeply about those around us We understand that what we do matters ­— to our patients, our employees and the communities in which we live and work. See how Our perspectives May 31, 2017 Living with MS: Understanding the Patient Experience See all perspectives About Us About Biogen A Leader In Multiple Sclerosis Executive Leadership Board of Directors History Manufacturing Biosimilars Positions & Policy Perspectives Contact Us Governance Research & Pipeline Pipeline Clinical Trials Access to Investigational Therapies BiogenScience Areas of Research Postdoc Program Collaborations Medical Research portal Therapies Multiple Sclerosis AVONEX® FAMPYRA® PLEGRIDY® TECFIDERA® TYSABRI® ZINBRYTA® Spinal Muscular Atrophy SPINRAZA® Biosimilars BENEPALI® FLIXABI® Partnered GAZYVA® RITUXAN® Responsibility Corporate Citizenship Supporting Patients Rethinking Resources Community & Foundation Acting Responsibly Grants Office Patients Medical Professionals Careers Investors Follow us on: Twitter LinkedIn Facebook YouTube Privacy Policy Terms & Conditions Sitemap Forward-Looking Statements Community Guidelines Contact Us © 2017 Biogen